文献速递肝病

肝硬化患者围手术期评估与管理:风险、结局与未来方向

Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-07-31

本文对1998-2018年87项研究进行叙述性综述,评估肝硬化患者非肝脏手术的围手术期结局。总体围手术期死亡率较无肝硬化患者高2-10倍,取决于肝功能障碍严重程度。代偿期肝硬化(CTP A级或MELD<10)择期手术死亡率增加甚微,CTP C级(或MELD>15)死亡风险高,应考虑肝移植或替代手术。现有风险计算器不充分,多数推荐基于病例系列和专家意见。

要点

  • 肝硬化患者围手术期死亡率较无肝硬化者高2-10倍,随肝功能障碍加重而升高。
  • 择期手术中,代偿期肝硬化(CTP A级或MELD<10)患者手术死亡率增加甚微。
  • CTP C级(或MELD>15)患者死亡风险高,应考虑肝移植或替代手术方案。

核心结论

  • 肝功能障碍严重程度、合并症及手术类型与复杂性(包括择期或急诊)均为肝硬化患者围手术期死亡率和并发症的决定因素。
  • 现有关于风险评估和围手术期管理的临床研究存在重大局限性,需进一步研究。

研究设计与样本

  • 叙述性综述,检索1998-2018年文献,纳入87项报告肝硬化患者围手术期结局的研究,提取手术类型、CTP分级和MELD评分相关的围手术期死亡率数据。

主要发现

  • 总体围手术期死亡率在肝硬化患者中较无肝硬化患者高2-10倍,取决于肝功能障碍严重程度。
  • 择期手术中,代偿期肝硬化(CTP A级或MELD<10)患者手术死亡率增加甚微。
  • CTP C级(或MELD>15)患者死亡风险高。
  • 指导肝硬化患者围手术期管理的数据很少,多数推荐基于病例系列和专家意见。
  • 现有风险计算器不充分。

关键数值与推荐

  • 代偿期肝硬化定义为CTP A级或MELD<10。
  • 高风险定义为CTP C级或MELD>15。
  • 总体围手术期死亡率在肝硬化患者中较无肝硬化患者高2-10倍。

临床怎么用

  • 根据肝功能障碍严重程度(CTP分级或MELD评分)、合并症及手术类型与复杂性评估围手术期风险。
  • 对CTP C级(或MELD>15)患者,应考虑肝移植或替代手术方案。

局限性

  • 指导围手术期管理的数据很少,多数推荐基于病例系列和专家意见。
  • 现有风险计算器不充分。
  • 现有风险评估和围手术期管理的临床研究存在重大局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with cirrhosis are at increased risk of perioperative morbidity and mortality. We provide a narrative review of the available data regarding perioperative morbidity and mortality, risk assessment, and management of patients with cirrhosis undergoing non-hepatic surgical procedures. METHODS: We conducted a comprehensive review of the literature from 1998-2018 and identified 87 studies reporting perioperative outcomes in patients with cirrhosis. We extracted elements of study design and perioperative mortality by surgical procedure, Child-Turcotte-Pugh (CTP) class and Model for End-stage Liver Disease (MELD) score reported in these 87 studies to support our narrative review. RESULTS: Overall, perioperative mortality is 2-10 times higher in patients with cirrhosis compared to patients without cirrhosis, depending on the severity of liver dysfunction. For elective procedures, patients with compensated cirrhosis (CTP class A, or MELD <10) have minimal increase in operative mortality. CTP class C patients (or MELD >15) are at high risk for mortality; liver transplantation or alternatives to surgery should be considered. Very little data exist to guide perioperative management of patients with cirrhosis, so most recommendations are based on case series and expert opinion. Existing risk calculators are inadequate. CONCLUSIONS: Severity of liver dysfunction, medical comorbidities and the type and complexity of surgery, including whether it is elective versus emergent, are all determinants of perioperative mortality and morbidity in patients with cirrhosis. There are major limitations to the existing clinical research on risk assessment and perioperative management that warrant further investigation.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Newman KL, Johnson KM, Cornia PB, et al. Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. Clin Gastroenterol Hepatol. 2019. PMID: 31376494. doi:10.1016/j.cgh.2019.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。